Evidence map›Paper›PMID 37033946›Full record

ArticleFrontiers in immunology2023

Macrophage-infectivity potentiator of

Magdalena Radwanska, Frédéric de Lemos Esteves, Loes Linsen, Nicolas Coltel, Sabrina Cencig, Joelle Widart, Anne-Cécile Massart, Séverine Colson, Alexandre Di Paolo, Pauline Percier and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. The macrophage infectivity potentiator ofFrontiers in immunology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Magdalena RadwanskaLaboratory of Parasitology, Faculty of Medicine, and ULB Center for Research in Immunology (UCRI), Université Libre de Bruxelles (ULB), Brussels, Belgium.
Frédéric de Lemos EstevesCenter for Protein Engineering (CIP), Université de Liège (ULg), Liège, Belgium.
Loes LinsenLaboratory of Parasitology, Faculty of Medicine, and ULB Center for Research in Immunology (UCRI), Université Libre de Bruxelles (ULB), Brussels, Belgium.
Nicolas ColtelLaboratory of Parasitology, Faculty of Medicine, and ULB Center for Research in Immunology (UCRI), Université Libre de Bruxelles (ULB), Brussels, Belgium.
Sabrina CencigLaboratory of Parasitology, Faculty of Medicine, and ULB Center for Research in Immunology (UCRI), Université Libre de Bruxelles (ULB), Brussels, Belgium.
Joelle WidartLaboratory of Mass Spectrometry (LSM), Department of Chemistry, Université de Liège, Liège, Belgium.
Anne-Cécile MassartLaboratory of Mass Spectrometry (LSM), Department of Chemistry, Université de Liège, Liège, Belgium.
Séverine ColsonCenter for Protein Engineering (CIP), Université de Liège (ULg), Liège, Belgium.
Alexandre Di PaoloCenter for Protein Engineering (CIP), Université de Liège (ULg), Liège, Belgium.
Pauline PercierLaboratory of Parasitology, Faculty of Medicine, and ULB Center for Research in Immunology (UCRI), Université Libre de Bruxelles (ULB), Brussels, Belgium.
Sarra Ait DjebbaraLaboratory of Parasitology, Faculty of Medicine, and ULB Center for Research in Immunology (UCRI), Université Libre de Bruxelles (ULB), Brussels, Belgium.
François GuillonneauLaboratory of Mass Spectrometry (LSM), Department of Chemistry, Université de Liège, Liège, Belgium.
Véronique FlamandInstitute for Medical Immunology (IMI), and ULB Center for Research in Immunology (U-CRI), Gosselies, Belgium.
Edwin De PauwLaboratory of Mass Spectrometry (LSM), Department of Chemistry, Université de Liège, Liège, Belgium.
Jean-Marie FrèreCenter for Protein Engineering (CIP), Université de Liège (ULg), Liège, Belgium.
Yves CarlierLaboratory of Parasitology, Faculty of Medicine, and ULB Center for Research in Immunology (UCRI), Université Libre de Bruxelles (ULB), Brussels, Belgium.
Carine TruyensLaboratory of Parasitology, Faculty of Medicine, and ULB Center for Research in Immunology (UCRI), Université Libre de Bruxelles (ULB), Brussels, Belgium.
University of Liège · BEUniversité Libre de Bruxelles · BEInstitute of Pathology and Genetics · BETulane University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work identifies the protein "macrophage infectivity potentiator" of

Indexed as

Trypanosoma cruziVaccinesAdjuvants, ImmunologicAlum CompoundsAnimalsAntigensHumansImmunoglobulin GInfant, NewbornMacrophagesMiceAdjuvants, ImmunologicAlum Compoundsaluminum sulfateAntigensImmunoglobulin GVaccinesadjuvantcord bloodgamma-interferonmacrophage infectivity potentiatorneonatal immunityTrypanosoma cruzitype 1 immune response

Identifiers

PMID37033946
PMCPMC10077492
OpenAlexW4360613850

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.